KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Change in Account Payables (2016 - 2019)

NovoCure (NVCR) has disclosed Change in Account Payables for 6 consecutive years, with $126000.0 as the latest value for Q2 2019.

  • Quarterly Change in Account Payables fell 87.6% to $126000.0 in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $9.6 million through Jun 2019, up 32.44% year-over-year, with the annual reading at $9.5 million for FY2018, 926.35% up from the prior year.
  • Change in Account Payables hit $126000.0 in Q2 2019 for NovoCure, down from $3.2 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.7 million in Q4 2018 to a low of -$6.8 million in Q3 2016.
  • Historically, Change in Account Payables has averaged $1.1 million across 5 years, with a median of $1.7 million in 2015.
  • Biggest YoY gain for Change in Account Payables was 371.28% in 2016; the steepest drop was 547.42% in 2016.
  • Year by year, Change in Account Payables stood at $2.4 million in 2015, then skyrocketed by 78.6% to $4.2 million in 2016, then fell by 27.45% to $3.1 million in 2017, then soared by 117.27% to $6.7 million in 2018, then crashed by 98.11% to $126000.0 in 2019.
  • Business Quant data shows Change in Account Payables for NVCR at $126000.0 in Q2 2019, $3.2 million in Q1 2019, and $6.7 million in Q4 2018.